List view / Grid view

Dr Enriqueta Felip

 

news

Roche cancer immunotherapy receives new EU approval

The subcutaneous injection of the novel cancer immunotherapy Tecentriq® (atezolizumab)…

16 January 2024 | By

The subcutaneous injection of the novel cancer immunotherapy Tecentriq® (atezolizumab) could provide a quicker alternative to intravenous infusion, research shows.